ImmunityBio (IBRX) Revenue Growth (1y) (2015 - 2026)
ImmunityBio (IBRX) Revenue Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 35.46% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 7.82% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 19.04% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 64.03% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | ImmunityBio | 7.60 Bn | 7.22 Bn | 43.97 Mn | 167.64% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 167.64% |
| Dec 31, 2025 | 406.95% |
| Sep 30, 2025 | 425.07% |
| Jun 30, 2025 | 2,423.88% |
| Mar 31, 2025 | 41,192.50% |
| Dec 31, 2024 | 5,333.09% |
| Sep 30, 2024 | 7,346.34% |
| Jun 30, 2024 | 2,453.66% |
| Mar 31, 2024 | -88.89% |
| Dec 31, 2023 | 90.41% |
| Sep 30, 2023 | -30.51% |
| Jun 30, 2023 | 17.14% |
| Mar 31, 2023 | 2,471.43% |
| Dec 31, 2022 | -81.28% |
| Sep 30, 2022 | 78.79% |
| Jun 30, 2022 | -89.68% |
| Mar 31, 2022 | -89.93% |
| Dec 31, 2021 | 1,757.14% |
| Sep 30, 2021 | -56.29% |
| Jun 30, 2021 | -22.25% |